As of November 7, 2026, Bristol Myers Squibb Co. is a publicly traded company (NYSE: BMY); its largest reported holder is Vanguard, with 7.49% on Schedule 13G of April 29, 2026, then State Street (5%). The largest insider holding is Sandra Leung, the general counsel and executive vice president, with 465,373.71 shares (0.02% of shares outstanding), per Form 4 of March 12, 2025 (Schedule 13G, April 29, 2026).
Is this your company?
About to sign with, pay or invest in Bristol Myers Squibb Co.? See the free Snapshot first.
Free to see. No signup.
Is Bristol Myers Squibb Co. a real, registered company?
- Bristol-Myers Squibb Co files with the SEC under CIK 14272 (its SEC filings).
- Its shares are listed under the ticker BMY on NYSE (also CELG-RI) (SEC company record).
- Incorporated in Delaware; business address in Princeton, New Jersey, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under BRISTOL-MYERS SQUIBB CO in our court records and SEC 8-K records (as of 2026-11-07).
- Layoffs: 5 state WARN notices (latest 2026-09-01, Princeton NJ, 265 employees).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names State Street (filed 2026-08-07).
Who are Bristol Myers Squibb Co.'s owners and officers?
Bristol Myers Squibb Co.: incorporated in Delaware; business address in Princeton, New Jersey; industry Pharmaceutical Preparations (Schedule 13G, 2026-08-07).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-07 | State Street Corporation | 5% |
| Schedule 13G, 2026-04-29 | Vanguard Capital Management | 7.49% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G/A, 2025-10-31 | Jpmorgan Chase & Co. | 4% |
Questions about who owns Bristol Myers Squibb Co.
Who owns Bristol Myers Squibb Co.?
On this page, 2 holders' latest ownership filings report 5% or more of Bristol Myers Squibb Co.: Vanguard Capital Management (7.49%, Schedule 13G, filed 2026-04-29) and State Street Corporation (5%, Schedule 13G, filed 2026-08-07).
Who are the largest shareholders of Bristol Myers Squibb Co.?
By the share each holder's latest filing reports, the largest holders of Bristol Myers Squibb Co. on this page are Vanguard Capital Management (7.49%) and State Street Corporation (5%).
When did Vanguard Capital Management buy into Bristol Myers Squibb Co.?
The filings give report dates, not purchase dates. The earliest filing from Vanguard Capital Management on this page is the Schedule 13G, filed 2026-04-29, reporting 7.49%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Bristol Myers Squibb Co.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Bristol Myers Squibb Co.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bristol Myers Squibb Co. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Bristol Myers Squibb Co. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the general counsel and executive vice president: 465,373.71 shares (0.02% of shares outstanding), 364,296.33 held directly and 101,077.38 indirectly (Form 4, 2025-03-12).
- , the chief financial officer and executive vice president: 159,542.42 shares (0.01% of shares outstanding), 159,248 held directly and 294.42 indirectly (Form 4, 2026-04-02).
- , the chief executive and a director: 148,536 shares (0.01% of shares outstanding), 23,097 held directly and 125,439 indirectly (Form 4, 2026-11-03).
- , the executive vice president and chief med.offr.: 83,513.49 shares (0.00% of shares outstanding) (Form 4, 2025-04-29).
- , the executive vice president and chief digital: 33,977 shares (0.00% of shares outstanding) (Form 4, 2026-11-03).
Shares outstanding: 2,044,085,831 as of 2026-10-21, from the company's latest SEC cover page.
How much has Bristol Myers Squibb Co. raised?
No fundraising or offering filing from Bristol Myers Squibb Co. is on file with us.
Keep reading
More on Bristol Myers Squibb Co. and the records around it.
Companies that share a holder
- JPMORGAN CHASE & CO. also filed stake reports on 116 other companies: LEVI STRAUSS & CO (Nov 2026), Warner Music Group Corp. (Nov 2026), Andersen Group Inc. (Oct 2026)
- STATE STREET CORPORATION also filed stake reports on 343 other companies: TRADE DESK INC/THE (Oct 2026), CENTRUS ENERGY CORP (Sep 2026), ACADIA PHARMACEUTICALS INC (Aug 2026)
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/bristol-myers-squibb